Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation

Hepatology

Volumn 21, Issue 1, 1995, Pages 14-18

  Angus, Peter W ^a   Locarnini, Stephen A ^b   McCaughan, Geoffrey W ^c   Jones, Robert M ^a   McMillan, Janine S ^b   Bowden, D Scott ^b  

^a AUSTIN HOSPITAL   (Australia)

^b FAIRFIELD HOSPITAL   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHOLESTASIS; CLINICAL ARTICLE; DISEASE ASSOCIATION; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS B VIRUS; HISTOLOGY; HUMAN; LIVER TRANSPLANTATION; PRIORITY JOURNAL; RECURRENT DISEASE; VIRUS CORE; VIRUS INFECTION; VIRUS MUTANT; VIRUS MUTATION; VIRUS REPLICATION;

CHOLESTASIS; DNA, VIRAL; GRAFT REJECTION; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HUMAN; LIVER TRANSPLANTATION; MUTATION; POSTOPERATIVE PERIOD; RECURRENCE; SURVIVAL ANALYSIS;

EID: 0028836094     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1016/0270-9139(95)90401-8     Document Type: Article

References (30)

1. Liver transplantation for patients with hepatitis B: what have we learned from our results?
2. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease
3. Hepatitis B virus reinfection after orthotopic liver transplantation
4. Evolution of hepatitis B virus liver disease after hepatic replacement: practical and theoretical considerations
5. Increased hepatocyte expression of hepatitis B virus transcription in patients with features of fibrosing cholestatic hepatitis
6. High level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis
7. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis
8. Medical aspects of liver transplantation
9. Liver transplantation today
10. Relevance of hepatitis B viral DNA in assessment of potential liver allograft recipients
11. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients
12. Serological and DNA follow-up data from HBsAg-positive patients treated with orthotopic liver transplantation
13. Genetic variations in hepatitis B virus
14. Precore mutant hepatitis B virus infection and liver disease
15. Long-term follow-up of anti-HBe-positive chronic active hepatitis B
16. Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen
17. Combination antiviral therapy controls severe post-liver transplant recurrence of hepatitis B virus infection
18. Fibrosing cholestatic hepatitis in a transplant recipient with hepatitis B virus precore mutant
19. Digoxigenin labelled probes for the detection of hepatitis B virus DNA in serum
20. A rapid method of sample preparation for detection of DNA viruses in human serum by polymerase chain reaction
21. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis
22. Cyclosporin A modulates the course of woodchuck hepatitis virus infection and induces chronicity
23. The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer
24. Hepatitis B virus heterogeneity, one of the many factors influencing the severity of hepatitis B
25. Persistent hepatitis B virus infection of mononuclear blood cells without concomitant liver infection: the liver transplantation model
26. Graft infection with hepatitis B (HBV) following liver transplantation (OLTx): prognostic importance of viral replication
27. Liver transplantation in HBs antigen (HBsAg) carriers
28. Recurrence of hepatitis B after liver transplantation: does hepatitis-B-immunoglobulin modify the recurrent disease?
29. Liver transplantation in European patients with hepatitis B surface antigen
30. HLA class 1 matching is responsible for the hepatic lesions in recurrent viral hepatitis B after liver transplantation